Search - tctmd.com

Displaying 821 - 840 of 1004

Sort: Relevancy | Date

News Daily News

CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery

L.A. McKeown

August 19, 2015

News Industry News

Biotronik launches 2 new studies

August 13, 2015

News Daily News

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

August 11, 2015

News Daily News

COMPARE: EES Maintains Advantage Over PES at 5 Years

Salynn Boyles

July 30, 2015

News Daily News

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Todd Neale

July 27, 2015

News Daily News

Registry Provides Reassurance About Rotational Atherectomy Pre-PCI

Todd Neale

July 23, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Industry News

FDA ruling allows heart valve patients to limit blood-thinning medication

July 08, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

CTOs Relatively Frequent in Patients Without Previously Known CAD

Nicole Lou

June 30, 2015

News Daily News

FDA Approves 2 New TAVR Systems for High-Risk, Inoperable Patients

Yael L. Maxwell

June 24, 2015

News Daily News

Study Explores Safety of Early Discharge After Transfemoral TAVR

L.A. McKeown

June 24, 2015

News Daily News

Catheter-Delivered Gene Therapy Yields Positive Signal in Advanced Heart Failure

June 23, 2015

News Industry News

Medtronic Announces FDA Approval for New TAVR System, Introduces First and Only Recapturable Heart Valve in U.S.

June 23, 2015

News Industry News

Boston Scientific Initiates Global Study To Assess EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) In Primary Prevention Patients With Low Ejection Fraction

June 22, 2015

News Daily News

Lotus Valve Tops CoreValve on Some Measures in Single-Center, Nonrandomized Study

L.A. McKeown

June 17, 2015

News Daily News

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Caitlin E. Cox

June 15, 2015

Advertisement

CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery

Biotronik launches 2 new studies

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

COMPARE: EES Maintains Advantage Over PES at 5 Years

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Registry Provides Reassurance About Rotational Atherectomy Pre-PCI

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

FDA ruling allows heart valve patients to limit blood-thinning medication

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

CTOs Relatively Frequent in Patients Without Previously Known CAD

FDA Approves 2 New TAVR Systems for High-Risk, Inoperable Patients

Study Explores Safety of Early Discharge After Transfemoral TAVR

Catheter-Delivered Gene Therapy Yields Positive Signal in Advanced Heart Failure

Medtronic Announces FDA Approval for New TAVR System, Introduces First and Only Recapturable Heart Valve in U.S.

Boston Scientific Initiates Global Study To Assess EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) In Primary Prevention Patients With Low Ejection Fraction

Lotus Valve Tops CoreValve on Some Measures in Single-Center, Nonrandomized Study

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content